- Home
- HCWB vs EFOI Comparison
HCWB vs EFOI Comparison
Compare HCWB & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- EFOI
- Stock Information
- Founded
- HCWB 2018
- EFOI 1985
- Country
- HCWB United States
- EFOI United States
- Employees
- HCWB N/A
- EFOI N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- EFOI Building Products
- Sector
- HCWB Health Care
- EFOI Consumer Discretionary
- Exchange
- HCWB Nasdaq
- EFOI Nasdaq
- Market Cap
- HCWB 10.8M
- EFOI 12.6M
- IPO Year
- HCWB 2021
- EFOI 1994
- Fundamental
- Price
- HCWB $5.59
- EFOI $2.45
- Analyst Decision
- HCWB Strong Buy
- EFOI
- Analyst Count
- HCWB 1
- EFOI 0
- Target Price
- HCWB $35.00
- EFOI N/A
- AVG Volume (30 Days)
- HCWB 5.7M
- EFOI 25.9K
- Earning Date
- HCWB 08-18-2025
- EFOI 11-11-2025
- Dividend Yield
- HCWB N/A
- EFOI N/A
- EPS Growth
- HCWB N/A
- EFOI N/A
- EPS
- HCWB N/A
- EFOI N/A
- Revenue
- HCWB $832,841.00
- EFOI $4,233,000.00
- Revenue This Year
- HCWB $178.36
- EFOI N/A
- Revenue Next Year
- HCWB N/A
- EFOI N/A
- P/E Ratio
- HCWB N/A
- EFOI N/A
- Revenue Growth
- HCWB N/A
- EFOI N/A
- 52 Week Low
- HCWB $2.77
- EFOI $1.14
- 52 Week High
- HCWB $100.80
- EFOI $2.95
- Technical
- Relative Strength Index (RSI)
- HCWB 60.31
- EFOI 54.10
- Support Level
- HCWB $3.25
- EFOI $2.43
- Resistance Level
- HCWB $6.66
- EFOI $2.54
- Average True Range (ATR)
- HCWB 0.77
- EFOI 0.14
- MACD
- HCWB -0.05
- EFOI -0.02
- Stochastic Oscillator
- HCWB 57.07
- EFOI 20.98
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.